VGNT Stock Analysis: Versigent | NYSE
Auto Parts | NYSE, USA | Market Cap: 3.128m USD | 12M Return: 37.7% | JE00BWK75100 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 32.2M
Rev. Trend: -2.3%
Warnings
Tailwinds
Seasonality 0.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Versigent PLC (NYSE: VGNT) designs, manufactures, and distributes low- and high-voltage power electrical architectures, with a product portfolio spanning signal and data connectivity solutions, power distribution systems, high-voltage electrical distribution systems, and EV charging solutions. The company serves the automotive, commercial vehicle, and energy and grid industries.
Founded in 2026 and headquartered in Schaffhausen, Switzerland, Versigent was spun off from Aptiv PLC on April 1, 2026, and now operates as an independent public company classified under the GICS Consumer Discretionary sector within the Automotive Parts & Equipment sub-industry.
The Automotive Parts & Equipment sub-industry includes manufacturers of components and systems supplied to vehicle OEMs, with suppliers focused on electrical architectures positioned to benefit from the broader industry shift toward vehicle electrification and increased demand for power and data distribution systems.
- EV charging revenue scales with fleet electrification adoption
- High-voltage distribution margins expand as automotive electrification accelerates
- Energy and grid segment drives growth post-spin capital allocation
| Net Income: 518.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.79 > 1.0 |
| NWC/Revenue: 10.90% < 20% (prev 8.97%; Δ 1.94% < -1%) |
| CFO/TA 0.12 > 3% & CFO 645.0m > Net Income 518.0m |
| Net Debt (2.07b) to EBITDA (972.0m): 2.13 < 3 |
| Current Ratio: 1.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (71.9m) vs 12m ago 1.17% < -2% |
| Gross Margin: 12.22% > 18% (prev 11.40%; Δ 0.83% > 0.5%) |
| Asset Turnover: 187.5% > 50% (prev 184.6%; Δ 2.92% > 0%) |
| Interest Coverage Ratio: 3.13 > 6 (EBIT TTM 744.0m / Interest Expense TTM 238.0m) |
| A: 0.19 (Total Current Assets 3.54b - Total Current Liabilities 2.53b) / Total Assets 5.36b |
| B: 0.02 (Retained Earnings 118.0m / Total Assets 5.36b) |
| C: 0.15 (EBIT TTM 744.0m / Avg Total Assets 4.93b) |
| D: 0.02 (Book Value of Equity 85.0m / Total Liabilities 5.08b) |
| Altman-Z'' = 2.34 = BBB |
| DSRI: 1.05 (Receivables 2.08b/1.77b, Revenue 9.24b/8.31b) |
| GMI: 0.93 (GM 11.40% / 12.22%) |
| AQI: 0.99 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 1.11 (Revenue 9.24b / 8.31b) |
| TATA: -0.02 (NI 518.0m - CFO 645.0m) / TA 5.36b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of October 15, 2026, the stock is trading at USD 42.56 with a total of 707,003 shares traded. Over the past week, the price has changed by -6.03%, over one month by -7.64%, over three months by +7.66% and over the past year by +37.66%.
Current recommended Stop Loss: 38.20 (which is 10.2% or 2.7 ATR below the current price).
Versigent has received a consensus analysts rating of 4.70. Therefore, it is recommended to buy VGNT.
- StrongBuy: 7
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 56.7 | 33.2% |
P/E Trailing = 6.4561
P/E Forward = 5.8377
P/S = 0.3384
P/B = 38.5011
Revenue TTM = 9.24b USD
EBIT TTM = 744.0m USD
EBITDA TTM = 972.0m USD
Long Term Debt = 2.07b USD (from longTermDebt, last quarter)
Short Term Debt = 208.0m USD (from shortTermDebt, last quarter)
Debt = 2.62b USD (from shortLongTermDebtTotal, last quarter) + Leases 199.0m
Net Debt = 2.07b USD (calculated: Debt 2.62b - CCE 554.0m)
Enterprise Value = 5.20b USD (3.13b + Debt 2.62b - CCE 554.0m)
Interest Coverage Ratio = 3.13 (Ebit TTM 744.0m / Interest Expense TTM 238.0m)
EV/FCF = 11.62x (Enterprise Value 5.20b / FCF TTM 447.0m)
FCF Yield = 8.60% (FCF TTM 447.0m / Enterprise Value 5.20b)
FCF Margin = 4.84% (FCF TTM 447.0m / Revenue TTM 9.24b)
Net Margin = 5.60% (Net Income TTM 518.0m / Revenue TTM 9.24b)
Gross Margin = 12.22% ((Revenue TTM 9.24b - Cost of Revenue TTM 8.11b) / Revenue TTM)
Gross Margin QoQ = 13.13% (prev 10.99%)
Tobins Q-Ratio = 0.97 (Enterprise Value 5.20b / Total Assets 5.36b)
Interest Expense / Debt = 9.08% (Interest Expense 238.0m / Debt 2.62b)
Taxrate = 29.30% (46.0m / 157.0m)
NOPAT = 526.0m (EBIT 744.0m * (1 - 29.30%))
Current Ratio = 1.40 (Total Current Assets 3.54b / Total Current Liabilities 2.53b)
Debt / Equity = 30.85 (Debt 2.62b / totalStockholderEquity, last quarter 85.0m)
Debt / EBITDA = 2.13 (Net Debt 2.07b / EBITDA 972.0m)
Debt / FCF = 4.63 (Net Debt 2.07b / FCF TTM 447.0m)
Total Stockholder Equity = 864.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.51% (Net Income 518.0m / Total Assets 5.36b)
RoE = 59.90% (Net Income TTM 518.0m / Total Stockholder Equity 864.8m)
RoCE = 25.34% (EBIT 744.0m / Capital Employed (Equity 864.8m + L.T.Debt 2.07b))
RoIC = 20.45% (NOPAT 526.0m / Invested Capital 2.57b)
WACC = 9.63% (E(3.13b)/V(5.75b) * Re(12.33%) + D(2.62b)/V(5.75b) * Rd(9.08%) * (1-Tc(0.29)))
Discount Rate = 12.33% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 60.50 | Cagr: 1.17%
[DCF] Terminal Value 69.26% ; FCFF base≈468.6m ; Y1≈427.9m ; Y5≈374.8m
[DCF] Fair Price = 40.10 (EV 4.91b - Net Debt 2.07b = Equity 2.84b / Shares 70.8m; r=9.63% [WACC]; 5y FCF grow -10.78% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -2.28 | Revenue CAGR: -0.08% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.70 | Chg30d=-3.33% | Revisions=-44% | Analysts=6
EPS current Year (2026-12-31): EPS=7.27 | Chg30d=-1.17% | Revisions=+55% | GrowthEPS=+0.0% | GrowthRev=+7.8%
EPS next Year (2027-12-31): EPS=7.72 | Chg30d=-1.12% | Revisions=+0% | GrowthEPS=+6.2% | GrowthRev=+3.0%
[Analyst] Revisions Ratio: +11% (up=9, down=7)